iFamily SC (114840) 🔎 In-depth
KOSDAQ · Price as of 2026-08-06 · Updated 2026-08-09
iFamily SC is classified officially under cosmetics manufacturing, but in practice it plans and produces color-cosmetics brands and distributes them at home and abroad, making it closer to a consumer company that earns money on brand and product-planning strength. Building on its color-cosmetics brands, it grew revenue sharply over several years and carries high profitability with an ROE of 20.9%, but this year revenue is holding while margins are squeezed, Q1 2026 operating profit fell steeply, and a decision to dispose of treasury shares followed recently. The key point to watch: if margins find a bottom and profit begins to grow again, the low valuation on last year's basis (P/E 5.71x, P/B 1.19x) and the high profitability come back as strengths, but if the profit decline lasts longer, cheap last-year metrics alone (with a forward P/E of 13.06x) explain less of the picture.
This page organises public market and filing data for information purposes. It is not a recommendation to buy or sell, nor investment advice. Metrics labelled “forward” are our own unverified estimates. Please verify with the original DART filings and decide at your own responsibility.
30-second brief
Pulled directly from the computed values below — not a separately written opinion.
What do the SourceComputedEstimateReading tags mean?
Source filings and exchange data · Computed calculated from public data · Estimate our own unverified projection · Reading drafted automatically, then rule-checked. See AI & Automation.
Core valuation metric
This stock's effective sub-sector is “Cosmetics Brands” (Retail, Consumer Goods & Food · Cosmetics), a type typically read first through forward P/E.
Cosmetics brands are growth-oriented consumer names whose sales and profits can shift quickly with new products, channel expansion, and overseas rollouts. Because future growth explains the price better than past results, forward P/E, based on expected earnings, is the first lens.
Price against earnings alone becomes unstable when earnings swing. Reading it together with price against assets helps gauge the downside.
This note explains how each sector is typically valued and is educational context only, not investment advice.
At-a-glance assessment financial health · growth · profitability · valuation
- Debt ratio, current ratio and interest burden all look healthy.
- Revenue rose 9.4% year over year, and the pace is slowing (3-year trend: rising).
- Most recent quarter (Q1 2026) revenue was 0.8% higher than a year earlier.
- ROE is 17.7% (controlling-interest basis). It is above the sector average.
- Operating margin is 10.5%.
- P/B is high versus peers, a stretch on an asset basis.
Ownership & governance As of 2025-12-31
Largest shareholder Kim Tae-wook 27.35% (individual)
Controlling bloc incl. related parties 41.7%
With the controlling bloc holding 42%, the ownership structure is stable.
🔎 In-depth analysis Reading
iFamily SC is a branding company that translates the value consumers want into products and services, classified officially under cosmetics manufacturing. In practice, its business centers on planning and producing color-cosmetics brands and distributing them at home and abroad. In other words, rather than a company that sells chemical materials, it is closer to a consumer company that earns money on brand and product-planning strength. It is a KOSDAQ-listed name with a market cap of about ₩124.7 billion, a small-to-mid size, so it is worth keeping an eye not only on the business itself but also on the effect a single disclosure such as a treasury-share disposal has on share count and the balance sheet.
The latest close is ₩8,310 and the market capitalization is ₩138.6 billion. The price sits above its 20-day moving average (₩8,064) and below its 60-day moving average (₩8,658). Short-term and medium-term trends are diverging, so the direction is best read separately. The RSI (a supplementary indicator that gauges the strength of gains versus losses over the past 14 days on a 0-100 scale) is 52.6, a neutral level. The one-month change is -0.1%, the three-month change is -18.9%, and the position relative to the 52-week high is -69.2%. Relative strength versus the KOSDAQ is 37 (on a 1-99 scale, converted from returns against the index over the past year with more weight on recent performance; higher means stronger than the market). It is stronger than roughly 36% of all stocks. Over the past three months it outpaced the index by 22.7%. Chart interpretation is best done alongside trading volume and the dates on which disclosures occur.
Latest annual (2025) revenue is ₩224.1 billion, with operating profit of ₩27.1 billion and net profit of ₩21.8 billion. The operating margin is 12.1%, and ROE (return on equity, how much is earned in a year on shareholders' equity) is 20.9%, a high level above the sector average. The debt ratio (debt against shareholders' equity) is 136.3%, but with a current ratio of 296.5% and an interest-coverage ratio of 66.6x, short-term liquidity and the capacity to cover interest have ample room, so the financial structure is stable. On last year's confirmed results, the P/E (how many times one year's profit the price is) is 6.59x and the P/B (how many times book value the price is) is 1.31x, on the low side for a company generating this level of profitability. That said, this year is a phase where profit is falling versus last year, so the low last-year P/E and this year's profit flow need to be viewed together for the picture to line up.
Revenue grew about threefold over four years, from ₩71.6 billion in 2021 to ₩224.1 billion in 2025, and operating profit over the same span rose from ₩5.6 billion to ₩27.1 billion. The company grew its top line quickly on color-cosmetics demand and expanding overseas sales. That said, the pace of growth is gradually moderating. In 2025, operating profit and net profit fell 19% and 23% respectively from the prior year, and in Q1 2026, with revenue nearly flat (+0.8%), operating profit dropped 48% year on year. Reflecting this, the outlook this year is set below last year, at about ₩221.2 billion in revenue, ₩13.7 billion in operating profit and ₩10.6 billion in net profit, giving a forward P/E of 13.06x. The reason the forward P/E is higher than last year's basis (5.71x) is not that the share price got more expensive but that this year's expected profit is lower than last year's. The core is where profit finds a bottom and begins to grow again; with revenue holding, if margins recover the picture can improve quickly.
Recent disclosures are largely treasury-share related. A June 11, 2026 decision to terminate a treasury-share acquisition trust contract, a May 27 treasury-share disposal result report, and a May 21 treasury-share disposal decision followed in sequence. Decisions to buy and sell treasury shares connect to shareholder returns and changes in the free float, so it is worth checking whether the size and purpose of the disposal move in step with the company's profit and cash-flow stamina.
The strengths are clear. Building on its color-cosmetics brands, it grew revenue sharply over several years; it carries high profitability with a 20.9% ROE and ample liquidity and interest-coverage capacity; and its valuation on last year's confirmed results (P/E 5.71x, P/B 1.19x) is on the low side for this profitability. The price has also fallen well off the 52-week high, into a depressed zone. On the other hand, the point to note is that this year is a phase where profit is falling versus last year. Revenue is holding, but margins are squeezed and Q1 operating profit dropped steeply, and the forward P/E of 13.06x reflects this profit decline. In sum, if margins find a bottom and profit begins to grow again, the low valuation and high profitability come back as strengths, whereas if the profit decline lasts longer, cheap last-year metrics alone explain less of the picture. So whether quarterly revenue and operating margin recover is the most important confirmation point.
🔎 Valuation vs peers Overvalued
Comparables with adjacent market cap within the chemicals sector.
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| TK Chemical | 1.25x | 0.11x | 5.36% |
| Noroo Paint | 9.31x | 0.37x | 4.78% |
| Purit | 8.35x | 1.15x | 15.23% |
Within chemicals, public-data comparables closest in market cap were considered first. The current P/E (how many times one year's profit the price is) is 6.59x and the P/B (how many times book value the price is) is 1.31x. That said, for lower-market-cap names, profit swings and capital-raising disclosures carry a large effect, so this was not judged on last year's confirmed-results metrics alone. The outlook box is based on a DART seasonality approximation.
Earnings outlook Estimate company-stated · verified
| Type | Period | Revenue | Operating profit | Net profit |
|---|---|---|---|---|
| This year | 2026 | ₩221.2 billion | ₩13.7 billion | ₩10.6 billion |
| Next quarter | Q2 2026 | ₩54.8 billion | ₩3.1 billion | ₩2.5 billion |
Price history Close · MA20 · MA60
The latest close is ₩8,310 and the market capitalization is ₩138.6 billion. The price sits above its 20-day moving average (₩8,064) and below its 60-day moving average (₩8,658). Short-term and medium-term trends are diverging, so the direction is best read separately. The RSI (a supplementary indicator that gauges the strength of gains versus losses over the past 14 days on a 0-100 scale) is 52.6, a neutral level. The one-month change is -0.1%, the three-month change is -18.9%, and the position relative to the 52-week high is -69.2%. Relative strength versus the KOSDAQ is 37 (on a 1-99 scale, converted from returns against the index over the past year with more weight on recent performance; higher means stronger than the market). It is stronger than roughly 36% of all stocks. Over the past three months it outpaced the index by 22.7%. Chart interpretation is best done alongside trading volume and the dates on which disclosures occur.
Relative performance stock vs index · start = 100
Excess return vs index · 3M +22.71% / 6M -29.24% / 12M -48.06%
Key metrics Computed vs sector median
Valuation
The P/E of 6.59x is below the sector median (14.15x). The P/B of 1.31x is above the sector median (0.90x).
Enterprise value (EV)
EV = market cap + net debt. It reflects cash and debt, so it captures the real cost of the whole business that market cap alone misses; lower multiples are cheaper relative to earnings or sales.
Profitability & financials
Return on equity (ROE) is 17.7%, above the sector average (4.0%). The operating margin is 10.5%. The debt ratio is 40.2%, so the financial structure is stable.
Growth FY2025 · annual report (consolidated)
| Item | 2023 | 2024 | 2025 | YoY |
|---|---|---|---|---|
| Revenue | $104.5M | $143.9M | $157.4M | +9.38% ↓ slower |
| Operating profit | $16.9M | $23.6M | $19.1M | -19.34% ↓ slower |
| Net profit | $14.0M | $19.9M | $15.3M | -22.85% ↓ slower |
| 5-year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $50.3M | $59.9M | $104.5M | $143.9M | $157.4M |
| Operating profit | $3.9M | $6.7M | $16.9M | $23.6M | $19.1M |
| Net profit | $2.6M | $5.4M | $14.0M | $19.9M | $15.3M |
| Revenue CAGR | 4-yr avg 33.00% | ||||
Revenue rose 9.4% year over year (2023 ₩148.7 billion → 2024 ₩204.9 billion → 2025 ₩224.1 billion), and the three-year trend is 'rising'. That said, the pace of growth slowed from the prior year. Operating profit fell 19.3% year over year. The decline widened. Over the 5 years on record, revenue compound annual growth (CAGR) is 33.0%. The two-year revenue CAGR is 22.8%. In the most recent quarter (Q1 2026), revenue was 0.8% higher than the same period a year earlier.
Latest quarterly results Source Q1 2026 · vs year-ago
Technical indicators Computed
What stands out
- ROE of 17.7% points to solid profitability.
- The balance sheet is stable in terms of debt and liquidity.
Points to watch
- Revenue rose 9.4% year over year, and the pace is slowing (3-year trend: rising).
- The price is high versus peers, so expectations already appear priced in.
Recent news & events searched · sourced
- 2026-06-11UpdateMaterial-fact report (decision to terminate treasury-share acquisition trust contract): confirm the return termsA disclosure related to cash returns or a change in share count. Check whether profit stamina and cash flow provide support. Source
- 2026-05-27UpdateTreasury-share disposal result report: confirm the return termsA disclosure related to cash returns or a change in share count. Check whether profit stamina and cash flow provide support. Source
- 2026-05-21UpdateMaterial-fact report (treasury-share disposal decision): confirm the return termsA disclosure related to cash returns or a change in share count. Check whether profit stamina and cash flow provide support. Source
Figure cross-check computed ↔ external
| Metric | Computed | External | Status | Source |
|---|---|---|---|---|
| Closing price | ₩8,310 | ₩8,310 | Confirmed | link |
| Latest quarterly results | revenue ₩54.8 billion, operating profit ₩3.7 billion | revenue ₩54.8 billion, operating profit ₩3.7 billion | Confirmed | link |
| Annual results | revenue ₩224.1 billion, operating profit ₩27.1 billion | revenue ₩224.1 billion, operating profit ₩27.1 billion | Confirmed | link |
| Shareholder-return disclosure (original text) | check the payout terms | check the payout terms | Confirmed | link |
| Shareholder-return disclosure (original text) | check the payout terms | check the payout terms | Confirmed | link |
| Shareholder-return disclosure (original text) | check the payout terms | check the payout terms | Confirmed | link |
| Outlook box basis | DART | DART | Confirmed | link |
Recent filings Source
- 2026-05-27OwnershipOfficers'/major-shareholders' holdings report
- 2026-05-27OwnershipOfficers'/major-shareholders' holdings report
- 2026-05-27OwnershipOfficers'/major-shareholders' holdings report
- 2026-05-27TreasuryTreasury-stock disposal decision
- 2026-05-21TreasuryMaterial-fact report
- 2026-05-21TreasuryMaterial-fact report
- 2026-05-15PeriodicQuarterly report
- 2026-05-13Shareholders' meeting notice
- 2026-04-28Disclosure
- 2026-04-28Shareholders' meeting notice
- 2026-04-23Disclosure
- 2026-04-01Shareholders' meeting notice
📖 Plain-language glossary — expand if you are new to this
- P/E
- How many times a year's net profit the price is worth (lower is cheaper relative to earnings). The P/E here is on trailing (last full-year) results; for companies whose earnings swing fast (memory chips and other cyclicals/high-growth), a forward P/E on this year's expected earnings is more accurate.
- P/B
- Price relative to net assets (equity). Around 1x means it trades near book value; below 1x means below book.
- P/S
- Price relative to a year's revenue — useful for growth companies with thin earnings.
- Net debt / EV
- Net debt = interest-bearing debt − cash. Negative means more cash than debt (net cash). EV (enterprise value) = market cap + net debt, closer to what it would cost to buy the whole business.
- EV/EBIT · EV/EBITDA · EV/Sales
- Enterprise value against operating profit (EBIT), EBITDA, or revenue. Unlike P/E these reflect debt and cash; lower is cheaper relative to earnings power or sales.
- FCF / FCF yield
- Free cash flow = operating cash − capex, the cash actually left over. FCF yield = FCF ÷ market cap; higher means more cash generated per unit of market value.
- Intrinsic value (DCF)
- Future free cash flow (or, for some capex-heavy but profitable names, forecast earnings) discounted to today to estimate per-share value. Because it shifts a lot with the discount-rate and growth assumptions, it is shown as a bear/base/bull range, and the basis and assumptions are disclosed in one line beneath it.
- ROE
- How much profit the company earns in a year on its equity (%). Higher means better returns on capital.
- EPS / BPS
- Earnings per share / net assets (book value) per share.
- Operating / net margin
- Profit left from the core business / final profit after tax and interest, per unit of revenue.
- Debt ratio
- Debt relative to equity (%). Higher means more reliance on borrowing (norms vary by sector).
- Current ratio
- Assets convertible to cash within a year against debt due within a year. Above 100% leaves some short-term headroom.
- Interest coverage
- How many times operating profit covers the interest owed. Below 1x means operating profit alone struggles to cover interest.
- Dividend yield / payout ratio
- The year's dividend as a % of today's price / the share of earnings paid out as dividends.
- Revenue CAGR
- Multi-year growth expressed as a single yearly average (compound annual growth rate).
- RSI (short-term signal)
- Whether recent price action is overheated or beaten down. Above 70 is overbought, below 30 oversold.
- MA20 / MA60 (moving averages)
- The 20- and 60-day average price. Price above them signals a firmer short-term trend.
- vs 52-week high
- How far below the past year's peak the price sits now (%).
All figures are for reference only; how they read varies by sector and over time.
Sources: Korea FSC market-price API (data.go.kr), OpenDART, KRX/KIND — public data only.
Bong Stocks presents public-data-based information for reference only. It is not investment advice and contains no target prices, ratings, or buy/sell recommendations. Verify independently before making any decision.